Trial Profile
Steroid Adjunctive Treatment at Initiation of Avonex Therapy for Patients With Mono-Symptomatic or Relapsing-Remitting Multiple Sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jun 2015
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary) ; Dexamethasone
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 26 Jul 2011 New trial record